Home
Search results “Generic drugs introduced in united states”
FDA on target to approve record number of generic drugs
 
06:41
Commissioner Scott Gottlieb details move that could lower cost of prescription medicine for millions on 'Journal Editorial Report'
Views: 2024 Fox News
Why Are Prescription Drugs So Expensive?
 
03:45
» Subscribe to NowThis World: http://go.nowth.is/World_Subscribe The First Amendment protects free speech, but there are some exceptions. How annoying can you be before it becomes illegal? Learn More: There's Actually Free Speech Zones http://www.cnn.com/2012/09/02/politics/rnc-protest-vermin-supreme/index.html?iref=allsearch First Amendment: An Overview http://www.law.cornell.edu/wex/first_amendment "The First Amendment of the United States Constitution protects the right to freedom of religion and freedom of expression from government interference." Who is the Reasonable Person? http://www.lclark.edu/live/files/7230-lcb144art1moranpdf "As the common law's most enduring fiction, the reasonable person fulfills a great many different roles across very different bodies of law." Harassment http://definitions.uslegal.com/h/harassment/ "Harassment is governed by state laws, which vary by state, but is generally defined as a course of conduct which annoys, threatens, intimidates, alarms, or puts a person in fear of their safety." Reasonable Person http://definitions.uslegal.com/r/reasonable-prudent-man/ "Reasonable or Prudent man is a hypothetical person used as a legal standard especially to determine whether someone acted with negligence." Watch More: Is Online Trolling Illegal? https://www.youtube.com/watch?v=vdVJ2L8SabU _________________________ NowThis World is dedicated to bringing you topical explainers about the world around you. Each week we’ll be exploring current stories in international news, by examining the facts, providing historical context, and outlining the key players involved. We’ll also highlight powerful countries, ideologies, influential leaders, and ongoing global conflicts that are shaping the current landscape of the international community across the globe today. More from NowThis: » Subscribe to NowThis News: http://go.nowth.is/News_Subscribe » Like NowThis World on Facebook: https://go.nowth.is/World_Facebook » Connect with Judah: Follow @judah_robinson on Twitter – Facebook: http://go.nowth.is/LikeJudah » Connect with Versha: Follow @versharma on Twitter – Facebook: http://go.nowth.is/LikeVersha http://www.youtube.com/nowthisworld
Views: 106081 NowThis World
This Is How One Company Is Bringing Down Costs of Generic Drugs | NBC Nightly News
 
02:27
Advocates say this company's approach to insurance companies and patients’ prescriptions could be the future. » Subscribe to NBC News: http://nbcnews.to/SubscribeToNBC » Watch more NBC video: http://bit.ly/MoreNBCNews NBC News is a leading source of global news and information. Here you will find clips from NBC Nightly News, Meet The Press, and our original series Debunker, Flashback, Nerdwatch, and Show Me. Subscribe to our channel for news stories, technology, politics, health, entertainment, science, business, and exclusive NBC investigations. Connect with NBC News Online! Visit NBCNews.Com: http://nbcnews.to/ReadNBC Find NBC News on Facebook: http://nbcnews.to/LikeNBC Follow NBC News on Twitter: http://nbcnews.to/FollowNBC Follow NBC News on Google+: http://nbcnews.to/PlusNBC Follow NBC News on Instagram: http://nbcnews.to/InstaNBC Follow NBC News on Pinterest: http://nbcnews.to/PinNBC This Is How One Company Is Bringing Down Costs of Generic Drugs | NBC Nightly News
Views: 3314 NBC News
Why aren't generic drugs coming to market sooner?
 
09:35
The FTC's recent $1.2 billion settlement over the drug Provigil has brought so-called "pay for delay" deals for generic drugs back into the spotlight. Opponents say these deals delay generic medications to market, costing consumers billions. But drug companies say that the deals help get generics to market by avoiding lengthy patent litigation. NewsHour's Megan Thompson reports.
Views: 3124 PBS NewsHour
Senator Warren Asks About Generic Drug Prices & FDA Oversight
 
04:56
Senator Elizabeth Warren's Q&A at a November 20, 2014 HELP Subcommittee on Primary Health & Aging hearing titled "Why Are Some Generic Drugs Skyrocketing In Price?"
Why Prescription Drugs Cost So Much | Michael Rea | TEDxKC
 
08:15
Would you be mad if you found out you were paying as much as 2000% more than your neighbor for a prescription? Furious, Michael Rea left his job as a pharmacist eight years ago to pursue a solution to the runaway cost of prescription drugs. Dr. Michael Rea founded Rx Savings Solutions in 2008 after routinely witnessing consumers struggling to pay for their medications. He noticed quickly at that time that consumers were paying much more than they needed to, which was attributable to a lack of information available to them. He set out on his mission to arm consumers with this information and add efficiency and transparency back into the world of pharmacy. Dr. Rea has been involved with research surrounding pharmacy transparency for over 10 years. He received his Doctor of Pharmacy degree from Creighton University. This talk was given at a TEDx event using the TED conference format but independently organized by a local community. Learn more at http://ted.com/tedx
Views: 19059 TEDx Talks
Top 10 DEADLIEST DRUGS APPROVED By The FDA
 
08:44
Welcome to Top10Archive! We frequently look to them as remedies, but some are a bit more detrimental than helpful. Though legalized and distributed by healthcare professionals, some prescription drugs are racked with adverse side effects. Using data gathered from the United States' Food and Drug Administration, this installment will cover the 10 most dangerous prescription drug pills. Specifically, we'll be looking at the most toxic prescription drugs to our bodies, not the overall death count. Support us by shopping on Amazon! http://tinyurl.com/njwyzzn 10. Metoclopramide 9. Infliximab 8. Tacrolimus 7. Zoledronic Acid 6. Dexamethasone 5. Clozapine 4. Rituximab 3. Bevacizumab 2. Prednisolone 1. Cyclophosphamide Voice Over Talent: www.JimDenisonVoice.com http://www.youtube.com/user/thought2
Views: 34512 Top 10 Archive
How Does The FDA Approve New Drugs?
 
03:29
How Powerful Is Russia? http://bit.ly/1Ov9jE1 » Subscribe to NowThis World: http://go.nowth.is/World_Subscribe For decades, Cuba's been under an embargo, but its relations with the U.S. are now easing. So how powerful is the communist nation? Learn More: Castro steps down as Cuban leader http://news.bbc.co.uk/2/hi/americas/7252109.stm "Cuba's ailing leader Fidel Castro has announced he will not accept another term as president, ending the communist revolutionary's 49 years in power." Anuario Estadistico de Cuba http://www.one.cu/aec2014/07%20Empleo%20y%20Salarios.pdf El presente capítulo tiene como objetivo mostrar la evolución de indicadores relacionados con el empleo, los salarios, la protección del trabajo, la seguridad social y la asistencia social. Cuban Immigrants in the United States http://www.migrationpolicy.org/article/cuban-immigrants-united-states "Cuba has occupied a unique place in U.S. immigration law and policy as a result of fraught political relations and geographic proximity between the two countries." US-Cuba agree commercial flights deal http://www.bbc.com/news/world-us-canada-35117319 "The United States and Cuba have agreed to restore regular commercial flights, in a deal that could jumpstart economic relations between the two countries." Music Track Courtesy of APM Music: "Concentration" _________________________ NowThis World is dedicated to bringing you topical explainers about the world around you. Each week we’ll be exploring current stories in international news, by examining the facts, providing historical context, and outlining the key players involved. We’ll also highlight powerful countries, ideologies, influential leaders, and ongoing global conflicts that are shaping the current landscape of the international community across the globe today. More from NowThis: » Tweet @NowThisNews on Twitter: http://go.nowth.is/News_Twitter » Subscribe to NowThis News: http://go.nowth.is/News_Subscribe » Like NowThis World on Facebook: https://go.nowth.is/World_Facebook » Connect with Judah: Follow @judah_robinson on Twitter – Facebook: http://go.nowth.is/LikeJudah » Connect with Versha: Follow @versharma on Twitter – Facebook: http://go.nowth.is/LikeVersha http://www.youtube.com/nowthisworld Special thanks to Aneeta Akhurst for hosting TestTube!
Views: 81005 NowThis World
How Does the FDA Approve a Drug?
 
07:38
Have you ever taken an over the counter medication for heartburn? How about an antibiotic for an ear infection? At some point pretty much all of us have visited a pharmacy to pick up a drug, but likely didn't consider where these drugs come from or how they are made. Whether you're talking about something for seasonal allergies or your grandparent's arthritis medication, the act of bringing a drug to market is long and complex. I'm not an expert, but HCT intern Rachel Hoffman is, and with her help, that's the topic of this week's Healthcare Triage. For those of you who want to read more, go here: http://theincidentaleconomist.com/wordpress/?p=63822 John Green -- Executive Producer Stan Muller -- Director, Producer Aaron Carroll -- Writer Mark Olsen -- Graphics http://www.twitter.com/aaronecarroll http://www.twitter.com/crashcoursestan http://www.twitter.com/johngreen http://www.twitter.com/olsenvideo And the housekeeping: 1) You can support Healthcare Triage on Patreon: http://vid.io/xqXr Every little bit helps make the show better! 2) Check out our Facebook page: http://goo.gl/LnOq5z 3) We still have merchandise available at http://www.hctmerch.com
Views: 53059 Healthcare Triage
Top 200 Drugs Pronunciation (Generic names/ Brand names)
 
20:12
Top 200 drugs pronunciation: 1. Analgesics 0:03 2. Anti-infectives 1:55 3. Cardiovascular 3:42 4. CNS 7:59 5. Endocrine 12:56 6. Gastrointestinal 15:17 7. Miscellaneous 16:33 8. Respiratory 17:23
Views: 138196 Vince Li
US Congress briefing on Indian drugs
 
01:44
US Congress prepares to look deeper into whether generic drugs manufactured outside the U.S. are making the grade and lawmakers want to know more about the quality of the drugs coming out of India.
Views: 149 ET NOW
United States Generic Drugs Market to be USD 210 Billion by 2024
 
01:13
For more Info: https://www.renub.com/united-states-generic-drugs-market-nd.php As per Renub Research analysis United States Generic Drugs Market is anticipated to be more than USD 210 Billion by the year 2024. It has approximately 80% share of total dispensing prescriptions. Now most of the physicians and hospitals like prescribe generic drugs as compared to branded drugs. What is a Generic Drug? It is a Pharmaceutical drug that has the same chemical composition as patented drug. It has the same Active Pharmaceutical Ingredient (API) as original, but may have different manufacturing process, excipients, color, taste and packaging. It is only allowed when the patent(s) of on original drug is expired. Request a free sample copy of the report: https://www.renub.com/contactus.php Generic Drugs Market in United States In 2007, the Food and Drug Administration (FDA) launched the Generic Initiative for Value and Efficiency (GIVE) to increase the number and a variety of generic products by modernizing and streamlining approval process for generic drugs in US. For making a generic drug, pharmaceutical companies are required to file an Abbreviated New Drug Application with FDA. Why Generic Drugs are more affordable than Branded Drugs? A branded drug has to go through many phases before coming into the market; initial phase is drug discovery, target identification and validation then Primary Screening, Secondary Screening, Lead Optimization, Pre-Clinical Animal Studies and various other tests. As new drug development is a complex process and involves various R & D of chemicals, but clinical trials and regulatory processes are also required to be approved for human use of drugs. How Drugs Development Process Works? According to some studies only 5 out of 5000 preclinical drugs are tested on the human for medical use out of those 5 drugs only 1 is approved by FDA. There are various stages involved in drug development. Drug Discovery and Target Validation: In this stage drug development company chooses a molecule, such as a protein or gene and test it with a drug. After testing multiple drugs only a few are selected for next stage. Preclinical Testing: It is divided into subcomponents: in vitro and in vivo testing. In vitro testing examines drug molecules interactions in test tubes in the lab setting. In vivo testing involves test is being done on animal models and other living cell cultures. These tests may take several years before going to next stage. Investigational New Drug Application Filing: At this stage an application is submitted to FDA before beginning human clinical trials. At this point FDA will scrutinize the outcomes of preclinical testing, side effects and other safety measures for an experimental drug. When IND got approved by FDA then it can move onto human trials. After IND approval a patented drugs' 20 year exclusivity period begins. Client can Purchase this Report in Sections from below link: Access full Research: https://www.renub.com/united-states-off-label-drugs-market-and-forecast-51-p.php Phase 1 Clinical Studies: At this stage testing involves a small group of healthy people from a dozen to a few in numbers and safety is taken as a primary concern. Now all the side effect of drug, how a drug is absorbed & elimination from the body is tested. Phase 2 Clinical Studies: After getting positive outcomes from Phase1, Phase 2 begins in this phase the number of patients grows from a few dozen to 100 or more patients who are suffering from disease. Safety is also a big concern at this point and short term side effects are also monitored closely. Phase 3 Clinical Studies: At this stage the number of patients for drug testing grow from a few hundred to thousands. It is the longest and costliest of all components of development process. New Drug Application Filing: At this point application is filed to FDA, with all the research and safety data of initial stages having tens of thousands to 100,000 or more pages. After getting affirmation from FDA, Prescription Drug User Fee Act (PDUFA) date is set 10 months. PDUFA Date and Decision: FDA will wait for PDUFA date for its decision. FDA has 3 choices: it can approve a drug, it can deny a drug or it can request additional information by sending a Complete Response Later (CRL). If a drug is approved by FDA, now it becomes immediately available for commercial production. Phase 4 Clinical Studies: After 8 steps an approved drug can used for medical purpose, but it doesn't mean it is not under scrutiny of FDA, FDA can request long-term safety measures, side effect and adverse effect of drug.
Views: 3 Renub Research
Top 100 Prescription Drugs: 1-25 WITH AUDIO (1/4)
 
05:06
This video series covers the top 100 drugs. This list is current as of 12/23/2016. Includes audio pronunciation, brand names, indication, and drug classification. Great for those studying for the Pharmacy Technician Certification Exam (PCTE) since the test covers the top 200 drugs. *CORRECTION: levothyroxine (Synthroid) is for hypothyroidism, NOT hyperthyroidism* 1. 0:12 levothyroxine 2. 0:23 hydrocodone/APAP 3. 0:40 amoxicillin 4. 0:51 lisinopril 5. 1:03 esomeprazole 6. 1:15 atorvastatin 7. 1:28 simvastatin 8. 1:42 clopidogrel 9. 1:54 montelukast 10. 2:08 rosuvastatin 11. 2:20 metoprolol 12. 2:30 escitalopram 13. 2:40 axithromycin 14. 2:50 albuterol 15. 3:04 hydrochlorothiazide (HCTZ) 16. 3:16 metformin 17. 3:26 sertraline 18. 3:36 ibuprofen 19. 3:47 zolpidem 20. 3:59 furozemide 21. 4:09 omeprazole 22. 4:22 trazodone 23. 4:31 valsartan 24. 4:42 tramadol 25. 4:55 duloxetine
Views: 81198 Sarah Takenaka
FDA Publicly Accuses Drug Companies Of Trying To Block Generic Meds
 
00:49
According to a report by Gizmodo, the United States' Food and Drug Administration published a list of pharmaceutical companies that it accuses of impeding the development of generic drugs. The list, released on Thursday, include big names like Novartis, GlaxoSmithKline, Pfizer, and Valeant Pharmaceuticals that it accuses of putting in place obstacles that delay the development of generic medications. The list was published following President Donald Trump's statement at a White House press conference last week, where he pledged to lower prescription drug costs. He claimed that “foreign, developed nations” are getting a “free-ride by setting drug prices at unfairly low levels, leaving American patients to pay for the innovation that foreign patients enjoy.” https://gizmodo.com/fda-publicly-shames-drug-companies-that-block-generic-m-1826074736 http://www.wochit.com This video was produced by YT Wochit News using http://wochit.com
Views: 97 Wochit News
Indian Generic Drugs and Medicines Banned By US
 
02:42
India Stands in Second Place in exporting drugs and Medicines, and as the quality of drugs is low FDA banns export of Indian Drugs. Visit our Website : http://V6news.tv Twitter : https://twitter.com/#!/V6News Facebook : http://www.facebook.com/V6News.tv Google+ : https://plus.google.com/109903438943940210337 V6 News Channel
Views: 2225 V6 News Telugu
Prescription Drugs Documentary 2017 : The TRUTH Behind Pharmaceutical Drugs! Must Watch
 
52:09
We Broke 70,000 Subscribers! To show our appreciation to our viewers, we have some FREE Giveaway Contests! To participate, click the links below and fill out your email address. We will announce the winners soon! 1. Free Iphone X http://financiallyfreetoday.org/iphoneX 2. Free $1000 Visa Card : http://www.financiallyfreetoday.org/1000USD 3. Free Account to Watch The Newest HQ Movies : http://financiallyfreetoday.org/HDMoviesFREE 4. Free Victoria Secret Gift card [$500] : http://financiallyfreetoday.org/victoriasecret 5.Free Disney Vacation : http://financiallyfreetoday.org/Disney Learn to make money from home [free] : http://www.clkmg.com/zionbar012/money1 .................................. Learn to make money from home [free] : http://www.clkmg.com/zionbar012/money1 .................................. ATTN: WE NO LONGER UPLOAD VIDEOS TO YOUTUBE. FROM NOW ON, WATCH NEW DOCUMENTARIES AT : HTTP://DOCOZONE.ORG WE JUST UPLOADED A NEW DOCUMENTARY AND WILL KEEP UPDATING DAILY! GO WATCH AT HTTP://DOCOZONE.ORG NO ADS, AND NO YOUTUBE BS :) 😍 ➡ IPHONE 8 GIVEAWAY - DocoZone Viewers Only! 😍 We just reached 13,000,000 Views! To Show Our Love To Our Viewers, We Will Give Away Three Iphones 8 For FREE! (as soon as they're out). Join Here ➡ http://vid.io/xcKT (simply insert your email) The Winners will be announced on our channel. Thanks For Watching Our Videos, We Love You Guys! Prescription Drugs Documentary 2017 : The TRUTH Behind Pharmaceutical Drugs! Must Watch Prescription drugs, like xanax, zantac, vicodins and others,are often prescribed by doctors to treat a variety of health issues; but theres a dark side to these pills. These are highly addictive and many patients can’t stop using them, and it gets worse - because these pills are often very expensive, addicts switch to cheaper substances - like street drugs. This is a very controversial documentary and we would like to warn you. Viewers discretion is advised ! Please support DocoZone by liking and sharing this video ! —————————————————————— Never miss another documentary - Subscribe to Docozone NOW! https://www.youtube.com/channel/UCDvN1pp1DHRZxLMelj_r1wQ?sub_confirmation=1 --------------------------------- RECOMMENDED DOCUMENTARIES : [ GO TO OUR CHANNEL TO SEE MORE ] TAMPAS’ WORST PRISON https://youtu.be/pYGZx3lNSYs BINGE WATCH PRISON DOCUMENTARIES PLAYLIST - https://www.youtube.com/playlist?list=PL3d3IlexYGWXyZq9c0BeH-PqovnwvUe_7 Worst prison in LA - https://youtu.be/rh8QL1rABkY New Orleans INSANE Gangs Documentary - https://youtu.be/0Gy_DMzUqK0 Los Zetas: Most Vicious Mexican Cartel EVER! https://youtu.be/bsG35MEeess Gangs in the US Military - https://youtu.be/ykwh1gySyrY
Views: 25273 DocoZone
Prescription Drugs : The Costco Kickbacks  - The Fifth Estate
 
21:51
Secret audio tapes and an exclusive television interview with an industry whistleblower reveal a shady practice that is industry-wide. A Fifth Estate investigation shows how Costco pressed one generic drug company for illegal payments to stock their products -- undermining government attempts to protect consumers. Two Costo executives pleaded guilty to professional misconduct in front of the Ontario College of Pharmacists and the company says it suspended the practices upon conclusion of its own internal investigation. Costco says it didn’t use the funds to “line our pockets” but on the contrary the payments “are used to defray our operating costs to allow us to pass the savings on to our customers.” Hear the secret audio tapes for the first time and meet the man who blew the whistle. And find out how Canadians could be saving billions on the cost of generic drugs. --- Subscribe for more videos from The Fifth Estate : http://bit.ly/25W8cpn Connect with The Fifth Estate online : Website : http://bit.ly/1d0FBxq Facebook : http://bit.ly/1UO9B8S Twitter : http://bit.ly/237VM8P Instagram : http://bit.ly/25W8SLs About the fifth estate : For four decades The Fifth Estate has been Canada's premier investigative documentary program. Hosts Bob McKeown, Habiba Nosheen, Gillian Findlay and Mark Kelley continue a tradition of provocative and fearless journalism. the fifth estate brings in-depth investigations that matter to Canadians – delivering a dazzling parade of political leaders, controversial characters and ordinary people whose lives were touched by triumph or tragedy.
Views: 90985 The Fifth Estate
The FDA and the Pharmaceutical Industry
 
01:33:53
Carpenter, author of Reputation and Power:Organizational Image and Pharmaceutical Regulation at the FDA will join us to discuss the FDA and the pharmaceutical industry. The U.S. Food and Drug Administration is the most powerful regulatory agency in the world. How did the FDA become so influential? And how exactly does it wield its extraordinary power? Carpenter traces the history of FDA regulation of pharmaceuticals, revealing how the agency's organizational reputation has been the primary source of its power, yet also one of its ultimate constraints. Sponsored by the USC Bedrosian Center as part of it's on-going Governance Salons. Daniel Carpenter is Allie S. Freed Professor of Government and Director of the Center for American Political Studies in the Faculty of Arts and Sciences at Harvard University. For the 2011-2012 academic year, he is a Walter Channing Cabot Faculty Fellow at Harvard, and a visiting researcher at the Institut d'Études Politiques at the Université de Strasbourg in France. He graduated from Georgetown University in 1989 with distinction in Honors Government and received his doctorate in political science from the University of Chicago in 1996. He taught previously at Princeton University (1995-1998) and the University of Michigan (1998-2002). He joined the Harvard University faculty in 2002. Dr. Carpenter mixes theoretical, historical, statistical and mathematical analyses to examine the development of political institutions, particularly in the United States. He focuses upon public bureaucracies and government regulation, particularly regulation of health and financial products. His dissertation received the 1998 Harold D. Lasswell Award from the American Political Science Association and as a book - The Forging of Bureaucratic Autonomy: Reputations, Networks and Policy Innovation in Executive Agencies, 1862-1928 (Princeton: Princeton University Press, 2001) - was awarded the APSA's Gladys Kammerer Prize as well as the Charles Levine Prize of the International Political Science Association. His recently published book on pharmaceutical regulation in the United States is entitled Reputation and Power: Organizational Image and Pharmaceutical Regulation at the FDA (Princeton: Princeton University Press, 2010), and has received the 2011 Allan Sharlin Memorial Award from the Social Science History Association. Professor Carpenter has held fellowships from the John Simon Guggenheim Foundation, the Radcliffe Institute for Advanced Study, the Center for Advanced Study in the Behavioral Sciences, the Brookings Institution and the Santa Fe Institute. He has received grants from the National Endowment for the Humanities, the National Science Foundation, the Robert Wood Johnson Foundation (Scholars in Health Policy 1998-2000, Investigator Award in Health Policy Research 2004-2007), the Alfred Sloan Foundation, the Russell Sage Foundation and the Safra Center for Ethics. In the past few years, Professor Carpenter is the winner of both the 2011 Herbert Simon Award of the Midwest Political Science Association for a scholar "who has made a significant career contribution to the scientific study of bureaucracy", as well as the 2011 David Collier Award of the American Political Science Association for career contributions to qualitative and multi-method research. In addition to his ongoing teaching and scholarship on the political economy of government regulation and health, Professor Carpenter has recently launched a long-term project on petitioning in North American political development, examining comparisons and connections to petitioning histories in Europe and India. He hopes to draw upon the millions of petitions in local, state and federal archives to create an educational, genealogical and scholarly resource for citizens, students and scholars.
Views: 37331 USC Price
Biologic Drugs and Biosimilars
 
07:21
What are biologic drugs? What about biosimilars? In a previous video we compared brand name and generic drugs. (https://www.youtube.com/watch?v=vqXrfzWgDkE) But we kind of left out a major player in the world of medicines; biologic drugs. These complicated little guys probably deserve a video all to themselves. Call them what you will -biologics, biotherapeutic medicines, or biopharmaceuticals- they're topic of this week's HealthCare triage. We had tons of help from Healthcare Triage intern Rachel Hoffman on this episode! Those of you who want to read more can go here: http://theincidentaleconomist.com/wordpress/?p=68795 John Green -- Executive Producer Stan Muller -- Director, Producer Aaron Carroll -- Writer Mark Olsen -- Graphics http://www.twitter.com/aaronecarroll http://www.twitter.com/crashcoursestan http://www.twitter.com/johngreen http://www.twitter.com/olsenvideo And the housekeeping: 1) You can support Healthcare Triage on Patreon: http://vid.io/xqXr Every little bit helps make the show better! 2) Check out our Facebook page: http://goo.gl/LnOq5z 3) We still have merchandise available at http://www.hctmerch.com
Views: 38965 Healthcare Triage
Generic Drugs Just Got More Dangerous - The Ring Of Fire
 
12:15
The FDA was supposed to issue new rules last year to make generic prescription drugs safer for American consumers. But so far, they’ve failed to take any action, which is leaving patients at risk and drug makers with a Get Out of Jail Free card. Ring of Fire’s Farron Cousins discusses this with attorney Howard Nations. Listen to Ring of Fire on Saturdays from 3pm - 6pm Eastern! Listen live via the Progressive Voices Channel on TuneIn: http://tunein.com/radio/Progressive-Voices-s189055/ Or find a station here: http://www.ringoffireradio.com/station/ Watch Ring of Fire every Sunday at 12pm Eastern/9am Pacific on Free Speech TV! Support Ring of Fire by subscribing to our YouTube channel: http://www.youtube.com/user/golefttv You can also support us here: http://www.ringoffireradio.com/support/ Your continued support keeps Ring of Fire on the air! Follow more of our stories at http://www.RingofFireRadio.com Be sociable! Follow us on: Facebook: http://www.facebook.com/RingofFireRadio Twitter: http://www.twitter.com/RingofFireRadio Google+: http://plus.google.com/118415831573195648557 Support us further by shopping on Amazon via our Amazon-Ring of Fire partnership link. A portion of the sales will come back to Ring of Fire at no extra cost to you. Bookmark and follow the link below and continue shopping as usual! Amazon - Ring of Fire partnership link: http://www.amazon.com/?tag=rinoffir-20
Views: 2279 The Ring of Fire
Conversation about drug pricing | Health care system | Heatlh & Medicine | Khan Academy
 
13:33
Dr. Laurence Baker talks to Sal about how drug prices are set. Created by Sal Khan. Watch the next lesson: https://www.khanacademy.org/science/health-and-medicine/health-care-system/v/health-care-costs-in-us-vs-europe?utm_source=YT&utm_medium=Desc&utm_campaign=healthandmedicine Missed the previous lesson? https://www.khanacademy.org/science/health-and-medicine/health-care-system/v/blue-cross-and-blue-shield?utm_source=YT&utm_medium=Desc&utm_campaign=healthandmedicine Health & Medicine on Khan Academy: No organ quite symbolizes love like the heart. One reason may be that your heart helps you live, by moving ~5 liters (1.3 gallons) of blood through almost 100,000 kilometers (62,000 miles) of blood vessels every single minute! It has to do this all day, everyday, without ever taking a vacation! Now that is true love. Learn about how the heart works, how blood flows through the heart, where the blood goes after it leaves the heart, and what your heart is doing when it makes the sound “Lub Dub.” About Khan Academy: Khan Academy is a nonprofit with a mission to provide a free, world-class education for anyone, anywhere. We believe learners of all ages should have unlimited access to free educational content they can master at their own pace. We use intelligent software, deep data analytics and intuitive user interfaces to help students and teachers around the world. Our resources cover preschool through early college education, including math, biology, chemistry, physics, economics, finance, history, grammar and more. We offer free personalized SAT test prep in partnership with the test developer, the College Board. Khan Academy has been translated into dozens of languages, and 100 million people use our platform worldwide every year. For more information, visit www.khanacademy.org, join us on Facebook or follow us on Twitter at @khanacademy. And remember, you can learn anything. For free. For everyone. Forever. #YouCanLearnAnything Subscribe to Khan Academy’s Health & Medicine channel: https://www.youtube.com/channel/UC1RAowgA3q8Gl7exSWJuDEw?sub_confirmation=1 Subscribe to Khan Academy: https://www.youtube.com/subscription_center?add_user=khanacademy
Views: 50100 Khan Academy
Elizabeth Warren - Generic Drugs Skyrocketing In Price
 
07:43
November 20, 2014. United States Senate Committee on Health, Education, Labor, and Pensions. Subcommittee on Primary Health and Aging hearing. Witnesses: The Honorable Elijah E. Cummings , Ranking Member, House Committee on Oversight and Government Reform, Washington, DC; Stephen W. Schondelmeyer, PharmD, PhD , Professor and Director, PRIME Institute, University of Minnesota College of Pharmacy, Minneapolis, MN; Stephen W. Schondelmeyer, PharmD, PhD , Professor and Director, PRIME Institute, University of Minnesota College of Pharmacy, Minneapolis, MN; Erez Vigodman , President and Chief Executive Officer, Teva Pharmaceutical Industries Ltd., North Wales, PA (invited); Arthur P. Bedrosian, JD, President and Chief Executive Officer, Lannett Company, Inc., Philadelphia, PA (invited); Jeffrey S. Aronin , Chairman and Chief Executive Officer, Marathon Pharmaceuticals, LLC, Northbrook, IL (invited); Carol Ann Riha, West Des Moines, IA; Scott Gottlieb, MD, Resident Fellow, American Enterprise Institute, Washington, DC; Aaron S. Kesselheim, MD, JD, MPH , Associate Professor of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA.
Views: 1272 Marie Marr
Branded Vs. Generic Drugs - TV9
 
05:55
Branded Vs. Generic ► Download Tv9 Android App: http://goo.gl/T1ZHNJ ► Subscribe to Tv9 Telugu Live: https://goo.gl/lAjMru ► Circle us on G+: https://plus.google.com/+tv9 ► Like us on Facebook: https://www.facebook.com/tv9telugu ► Follow us on Twitter: https://twitter.com/Tv9Telugu ► Pin us on Pinterest: https://www.pinterest.com/Tv9telugu
Views: 8807 TV9 Telugu
Generic Drug Stocks
 
04:39
http://profitableinvestingtips.com/investing-tips/generic-drug-stocks Generic Drug Stocks By www.ProfitableInvestingTips.com. Pharmaceutical companies that make generic drugs were once a niche market. Today generic drug companies are set to bypass the makers of brand name drugs in sales value and volume according to About Money. Just a few years ago generic drug makers owned just a small slice of the pharmaceutical drug market. Today generics are a formidable segment of the industry and are on track to surpass branded drugs in sales value as well as sales volume within a few years, according to industry analysts. In the United States - where about 80 percent of all scripts written are for generics -- and traditional markets in Europe, multinational branded firms feeling losses from the patent cliff, health care reform legislation and austerity, are forming partnerships with their generic competitors to tap the expansion in generic sales. The top worldwide generic drug stocks and their 2012 generic drug sales are the following: • Teva, $10.4 billion • Mylan, $5.8 billion • Hospira, $4.1 billion • Sanofi, €1.8 billion • Ranbaxy Laboratories Ltd., $2.3 billion • Aspen Pharmacare Holding Ltd., 15.3 billion rand • STADA Arzneimittel AG, €1.2 billion Teva is the clear leader and Teva wants to take over Mylan. Teva to Acquire Mylan The New York Times reports that two generic drug stocks may become one as Teva seeks to acquire its rival Mylan. The deal making reached a fevered pitch on Tuesday when Teva, an Israeli maker of generic drugs, made an unsolicited $40 billion offer for Mylan, a rival based in the Netherlands. Getting bigger gives you better pricing and better leverage and also gets you into more markets.” This is especially true for generic drug makers, which rely less on research and development and more on maximizing profits from increasingly large global operations. Teva makes the case that by taking over Mylan they will add to their lead among generic drug stocks and increase annual revenue to around $30 billion as well as realize about $2 billion in cost savings. What Are Generic Drug Stocks? The Food and Drug Administration defines generic drugs. A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to a brand/reference listed drug product in dosage form, strength, quality and performance characteristics, and intended use." And generic drugs are cheaper than brand name drugs. This is because generic drug companies do not have the same research and development costs that big pharmaceutical companies have. They simply wait for the patent to expire on new blockbuster medications and make an identical medication for much less money. There are all sorts of new miracle drugs in the world and they are simply too expensive for the vast majority of people who take them. Generic drug stocks prosper because they provide necessary medications for the likes of the aging of populations in North America, Europe and Japan which increase their prescribed drug consumption every year. Should You Invest in Generic Drug Stocks? No matter how attractive generic drug stocks may seem fundamental stock analysis will tell you if a stock or a pending deal has good intrinsic value or not. There are pitfalls that Teva could fall into and not succeed in acquiring Mylan. These are antitrust concerns and a Mylan poison pill. If you are interested in generic drug stocks do your homework first. http://youtu.be/N113JpVAxok
Views: 241 InvestingTip
Regulatory Matters, US‐View
 
17:35
Spaeker: Dr. Wenlei Jiang, Deputy Director (Acting), Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, U.S. Food & Drug Administration (FDA) Silver Spring, MD (USA) "Assessing Complex Drug Similarity ‐ The Regulation of Follow‐on Nanomedicines & Non‐Biologic Complex Drugs (NBCDs)" Chair Prof. Dr. Daan J.A. Crommelin, Emeritus Professor at the Department of Pharmaceutics, Utrecht University (NL), Adjunct Professor at the Department of Pharmaceutics and Pharmaceutical Chemistry at the University of Utah (USA), Co‐founder of Octoplus, Leiden (NL) Day 1 Hall Montreal CLINAM 2015 The European Summit for Clinical Nanomedicine and Targeted Medicine – The Translation to Knowledge Based Medicine Eighth Conference and Exhibition, June 29 2015
Views: 141 TAUVOD
Why prescription drugs are more expensive in US than overseas
 
07:02
Former Health & Human Services Secretary Michael Leavitt on why some drugs are more expensive in the U.S. than overseas.
Views: 524 Fox Business
Will Trump's drug prices plan make a difference for patients?
 
10:34
President Trump revealed his blueprint to lower prescription drug prices as he railed against the pharmaceutical industry for making them unaffordable. Under his plan, "American Patients First," Trump proposes making it easier for generic drugs to enter the market and requiring drug makers to list prices in advertising. John Yang gets reaction from David Mitchell of Patients for Affordable Drugs. Find more from PBS NewsHour at https://www.pbs.org/newshour Subscribe to our YouTube channel: https://bit.ly/2HfsCD6 Follow us: Facebook: http://www.pbs.org/newshour Twitter: http://www.twitter.com/newshour Instagram: http://www.instagram.com/newshour Snapchat: @pbsnews Subscribe: PBS NewsHour podcasts: https://www.pbs.org/newshour/podcasts Newsletters: https://www.pbs.org/newshour/subscribe
Views: 5777 PBS NewsHour
Canadian Drug Prices: 2nd Highest Behind the United States
 
05:46
Canadians are still paying more for generic drugs than those in foreign markets thanks to a pricing model that one expert calls "uniquely stupid." As outrage continues to gather in the US over "pharma bro" Martin Shkreli and price gouging, a new report released this week found wild discrepancies in the cost of generics in Canada versus outside. The Patented Medicine Prices Review Board (http://pmprb-cepmb.gc.ca/home), Canada's drug price watchdog, compared the cost of 554 leading generic drugs — substances that treat everything from cardiovascular and gastrointestinal ailments to central nervous system conditions and diabetes — in Canada to those in 11 other industrialized countries, including the US, a number of European countries, as well as Australia and New Zealand. "Nobody in the world is as foolish in how they buy generic drugs are we are," says Amir Attaran, a law professor at the University of Ottawa and Canada Research Chair in law, population health and global development policy, in an interview. The higher prices are costing the Canadian taxpayer a billion dollars a year, and generics companies "are laughing at us," said Attaran. In Canada, prices are determined by provinces and territories, which commit to paying a certain percentage of the cost of brand name drugs for the generic versions. In Saskatchewan, for example, that price is 25 percent of the cost of brand name products. Ontario, on the other hand, now has a tiered pricing system. For example, if there are two existing sources for generics, the province would pay half of the branded price. If there are three or more sources, the amount drops. For 14 of the most common generic drugs — used to treat a variety of conditions including high cholesterol, high blood pressure, nerve pain, and diabetes — provinces and territories have formed the pan-Canadian Pharmaceutical Alliance (pCPA) to buy in bulk at 18 percent of the cost of an equivalent brand name product. "This percentage targeting is plain stupid," said Attaran. "It's the wrong way to do it because [the percentage] may give you a perfectly reasonable price or it may be too high for other medicines. It may also be too low for others, and if it's too low, no one's going to sell to you." He called the percentages arbitrary and compared the system to a dealership selling all used cars at 25 percent the cost of a new car. "That's a great deal if the used car is a year old and in mint shape, but what if the thing is a 20-year-old wreck?" Drug price gouging made headlines last year after Martin Shkreli jacked up the price of a patented drug used to treat parasitic infections by more than 5,500 percent. The impact of this price difference is ultimately felt by the consumer, said Joel Lexchin, who teaches health policy at York University in Toronto. "If you're paying out of pocket, you're paying more, and if you're getting your drugs covered through private insurance, your premiums are higher," he explained. If your medication is covered by a provincial drug plan, Lexchin continued, you're paying more in tax dollars. Tax dollars could also cover a wider range of drugs if the prices of generics are lowered. According to both Lexchin and Attaran, Canada would do well to look to New Zealand's system of tendering — in which the country announces the need for a certain drug, lets suppliers compete and chooses the lowest bidder — as an example for how drug price regulations can be improved. The model "gives companies the best price forward because if they get the deal, they're supplying all of New Zealand," Attaran explained. "What they lose in profit margin, they gain in volume." But Lexchin cautioned that having a single supplier for a particular drug also has its risks. There must be safety mechanisms in place in case of an emergency, like a fire at a manufacturing plant, which would prevent the production of and access to the drug, he said. Universal prescription drug coverage in Canada: Long-promised yet undelivered https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094297/ Health minister vows to save Canadians 'billions' on drug prices http://www.cbc.ca/news/health/health-minister-jane-philpott-drug-prices-1.3932254 Federal health minister plans to save billions on drug prices, but needs to commit to pharmacare https://canadians.org/blog/federal-health-minister-plans-save-billions-drug-prices-needs-commit-pharmacare Provincial and Territorial Public Drug Benefit Programs http://www.hc-sc.gc.ca/hcs-sss/pharma/acces/ptprog-eng.php
Views: 150 Our Amazing World
FDA Commissioner Dr. Scott Gottlieb Speaks Out on Need for Generic Competition
 
03:41
During the week of July 17, 2017, Dr. Scott Gottlieb, Commissioner of the Food and Drug Administration, spoke out about the need to curb anti-competitive practices employed by some brand pharmaceutical companies to keep generic competition off the market. By blocking safe, effective and affordable generic alternatives, these brand companies are able to retain their monopolies past the expiration of their patents and artificially preserve their high prices. The Congress is considering two bills to curb these anti-competitive, anti-patient schemes, the FAST Generics Act in the U.S. House of Representatives and the CREATES Act in the United States Senate. The Association for Accessible Medicines urges swift passage of these important bills to provide patients with relief from the high cost of medicine. Learn more at http://www.stopREMSabuse.com.
Marketing to Doctors: Last Week Tonight with John Oliver (HBO)
 
17:13
Pharmaceutical companies spend billions of dollars marketing drugs to doctors. We have a few issues with that. Connect with Last Week Tonight online... Subscribe to the Last Week Tonight YouTube channel for more almost news as it almost happens: www.youtube.com/user/LastWeekTonight Find Last Week Tonight on Facebook like your mom would: http://Facebook.com/LastWeekTonight Follow us on Twitter for news about jokes and jokes about news: http://Twitter.com/LastWeekTonight Visit our official site for all that other stuff at once: http://www.hbo.com/lastweektonight Connect with Last Week Tonight online... Subscribe to the Last Week Tonight YouTube channel for more almost news as it almost happens: www.youtube.com/user/LastWeekTonight Find Last Week Tonight on Facebook like your mom would: http://Facebook.com/LastWeekTonight Follow us on Twitter for news about jokes and jokes about news: http://Twitter.com/LastWeekTonight Visit our official site for all that other stuff at once: http://www.hbo.com/lastweektonight
Views: 9739294 LastWeekTonight
Indian Supreme Court Protects Low Cost Life Saving Drugs (with Prof. Brook K. Baker)
 
10:09
The importance of the Indian Supreme Court's decision on generic drugs, why the bar is lower for generic drug production in the United States,why Pharma companies drive inefficiency and threaten global health, why pharma companies are primarily marketing firms , why medicine is a "Global Public Good" and why "free trade agreements" are simply a giveaway for corporations... This clip from the Majority Report, live M-F at 12 noon EST and via daily podcast at http://Majority.FM Subscribe to us on YouTube: http://youtube.com/user/SamSeder
Supreme Court Rules in Favor of Generic  Drug Preemption
 
04:22
The United States Supreme Court held in Pliva, Inc. v. Mensing that federal drug labeling laws directly conflict with, and therefore impliedly preempt, state law failure-to-warn claims against generic drug manufacturers. Mensing is the latest in a series of federal preemption cases involving the pharmaceutical and medical device industry
Views: 278 tcdevoto
How Many Prescriptions Are Filled Each Year In The United States?
 
00:45
Billion prescriptions filled in 2011 live science. One of the reasons drug prices are much higher in us compared to other an additional 2 million packages pharmaceuticals arrive annually by or failed fill a prescription same year because cost 15 apr 2014 per capita use and overall spending on medications united first time 3 years, according report released april 15, 2014, states 2013, reviewed costs number physician office visits, hospitalizations, prescriptions filled all increased 2013 17 sep 2010 30 old anxiety is most prescribed mental health. Why do americans spend so much on pharmaceuticals? . In 2014 were filled using generic it is evident that annual spending on many medication classes would soar in the. Over prescribed america top master's in healthcare administration. Adults reported taking a psychiatric drug, such as an 17 percent of adults in the u. Pbs opioid prescriptions across the u. Difficulties among children aged 6 17 years in the united states, 12 number of prescriptions filled by average american each year $234 billion amount money spent on prescription drugs u. Spending on prescription drugs soared last year, driven up rose 13 percent the largest annual increase since 2001. Prescription drug spending to hit $400 billion a year by 2020 ims. Reported filling at least one prescription for a in addition, nearly twice as many women men reported taking because the survey data included information on only single year, all rights reserved 7 feb 2014 united states spends more pharmaceuticals every year than any percentage of adults who did not fill or skipped doses 1 aug 2017 5 u. America's most popular mind medicines forbes. 2013 total number of retail prescription drugs filled at pharmacies. Prescription drug use and spending on the rise pharmacy times. Drug spending growth reaches 8. Prescription drug spending and a 10 percent jump last year in the number of prescriptions filled, to nearly 4. S14 apr 2016 americans spent a combined $309. Annual spending on prescription medicines will increase 22 percent research pipelines filled with innovative should ensure a high has so far approved two biosimilars, many more in development 12 sep 2012 use of drugs the united states continues to rise, slightly than 4 billion prescriptions last year, according new analysis. Generic drug savings in the united states association for. Americans consume almost all of the global opioid supply cnbc. All of these factors made 2014 an especially notable year for 3 may 2017 accidents or unintentional injuries all assault homicide suicide and self inflicted injury percent persons using at least one prescription drug in the past 30 days source health, united states, 2016, table 79[pdf 9. Health care system is in a state of flux,' wrote some these drugs were new treatments for diseases like hepatitis c, multiple sclerosis and cancer. Because many people switched from taking brand name drugs to generic versions in 2011, the top sellers copyright 2017 all righ
Views: 14 Duck the Question
Made In India-Pharmaceutical Industry-2015
 
09:19
The Pharmaceutical industry in India is the world's third-largest in terms of volume. According to Department of Pharmaceuticals the total turnover of India's pharmaceuticals industry between 2008 and 2009 was US$21.04 billion. India is one of the fastest-growing pharmaceutical markets in the world and has established itself as a global manufacturing and research hub. A large raw material base and the availability of a skilled workforce gives the industry a definite competitive advantage. India is today one of the top emerging markets in the global pharmaceutical scene. The sector is highly knowledge based and its steady growth is positively affecting the Indian economy. The organized nature of the Indian pharmaceutical industry is attracting several companies that are finding it viable to increase their operations in the country. In 2013, there were 4,655 pharmaceutical manufacturing plants in all of India, employing over 345 thousand people The government of India started to encourage the growth of drug manufacturing by Indian companies in the early 1960s, and with the Patents Act in 1970. However, economic liberalization in 1990s enabled the industry to flourish. Indian companies carved a niiche in both the Indian and world markets with their expertise in engineering new processes for manufacturing drugs at low costs. Although some of the larger companies have taken small steps towards drug research and innovation, the industry as a whole has been following this business model until the present. The Indian pharmaceutical industry was estimated to be worth US$ 23 billion in 2 thousand 10 and is expected to touch US$ 55 billion by 2016. Globally, India ranks third in terms of volume of production and fourteenth largest by value. The domestic market is likely to grow from US$ 13 billion in 2010 to US$ 25 billion by 2017. The domestic pharma sector is witnessing strong growth due to higher penetration in tier-2 and tier-3 cities and greater focus on the largely- untapped rural market. The major factors responsible for this growth are increasing sales of generic medicines, continued growth in chronic therapies and greater penetration in rural markets. India exports to more than 200 countries; its share of exports is expected to grow incrementally. Pharmaceutical exports grew from US$ 8.6 billion in 2008 to US$ 14.5 billion in 2012, at a rate of 13.8 per cent. The US is India’s largest importer. The exports to the US grew at a rate of around 24 per cent between 2006 and 2010. The export of bulk drugs continue to grow to regulated markets and is supported by India’s existing foothold in semi-regulated market. India currently exports drug intermediates, Active Pharmaceutical Ingredients, Finished Dosage Formulations Bio-Pharmaceuticals, and Clinical Services across the globe. The exports of pharmaceuticals from India grew to US$ 14.6 billion in 2012from US$ 6.23 billion in 2006, registering a compound annual growth rate of around 15.2 per cent. India, with almost 200, US FDA drug manufacturing facilities, is the biggest foreign supplier of medicines to the United States . Exports to the US rose nearly 32 per cent last year to US$ 4.23 billion. India accounts for nearly 40 per cent of generic drugs and over-the-counter products and 10 per cent of finished dosages used in the US. Generic drugs have a dominant position in the rapidly expanding Indian drug industry. India's exports of generic drugs have been growing at a rate of 24 per cent over the past four years. In the period 2002 to 2012, the country’s healthcare sector grew 3 times in size, touching US$ 70 billion from US$ 23 billion. The Top 10 Publicly Listed pharma companies in India by Market Capitalization as of 2015 are Sun Pharmaceutical, Lupin Pharmaceuticals, Dr. Reddy's Labs, Cipla, Aurobindo Pharmaceutical, Cadila Healthcare, Glenmark Pharmaceuticals, Divis Labs and Torrent Pharmaceuticals. The Indian pharma industry is on a good growth path and is likely to be in the top 10 global markets in value terms by 2 thousand 20, according to the Price water cooper report. High burden of disease, good economic growth leading to higher disposable incomes, improvements in healthcare infrastructure and improved healthcare financing are driving growth in the domestic market, the report highlighted. The small and medium enterprises are expected to play a significant role in the growth story of the country's pharma sector as they contribute 35–40 per cent to the industry in terms of production
Views: 33069 KoSh Films
Pharma Price Gouging Out of Control - The Ring Of Fire
 
11:33
Last week, Martin Shkreli managed to make the entire United States angry by buying the rights to a generic drug and then raising the price by over 5,000% overnight. What Shkreli did is deplorable, but he didn’t invent that scheme – that’s how Big Pharma has been operating for decades. For more on this, let’s check in with Howard Nations.… Follow more of our stories at http://www.RingofFireRadio.com Spread the word! LIKE and SHARE this video or leave a comment to help direct attention to the stories that matter. And SUBSCRIBE to stay connected with Ring of Fire's video content! Listen to Ring of Fire on Saturdays from 3pm - 6pm Eastern! Listen live via the Progressive Voices Channel on TuneIn: http://tunein.com/radio/Progressive-Voices-s189055/ Or find a station here: http://www.ringoffireradio.com/station/ Watch Ring of Fire every weekday at 8:30pm EST on Free Speech TV! Support Ring of Fire by subscribing to our YouTube channel: http://www.youtube.com/user/golefttv You can also support us here: http://www.ringoffireradio.com/support/ Your continued support keeps Ring of Fire on the air! Be sociable! Follow us on: Facebook: http://www.facebook.com/RingofFireRadio Twitter: http://www.twitter.com/RingofFireRadio Google+: http://plus.google.com/118415831573195648557 Support us further by shopping on Amazon via our Amazon-Ring of Fire partnership link. A portion of the sales will come back to Ring of Fire at no extra cost to you. Bookmark and follow the link below and continue shopping as usual! Amazon - Ring of Fire partnership link: http://www.amazon.com/?tag=rinoffir-20
Views: 1116 The Ring of Fire
How to Buy Prescription Drugs in Mexico without a Prescription
 
08:23
As a full time RVer, medical insurance and prescription management can be challenging. Recently I ran out of my migraine medicine so took a trip to Mexico to buy my meds over the counter. This video shows how to buy prescription drugs in Mexico and answers questions about what can and can NOT be bought. Watch and join me as I visit Mexico with my friend Bob to stock up on prescription medicine.
Views: 98788 Carolyn's RV Life
US Generic Drug Market Share, Size Trends and Forecast 2017-2022
 
00:41
To get more information about the market, please visit @ http://www.imarcgroup.com/us-generics-market The US generic drug market has witnessed a transformation over the last three decades. From less than 20% of the total prescriptions, generic drugs now account for the majority of the total prescriptions dispensed in the United States. Request sample of the report: http://www.imarcgroup.com/request?type=report&id=567&flag=B Find latest reports from Healthcare industry: http://www.imarcgroup.com/categories/healthcare-market-research-reports Contact Us IMARC Group USA: +1-631-791-1145 Email: sales@imarcgroup.com Website: http://www.imarcgroup.com Follow us on twitter : @imarcglobal
The 10 Most Prescribed Drugs in America
 
01:58
Here are the 10 most prescribed drugs in America
Views: 506 The Fiscal Times
India's drug-patent rules
 
06:13
As pharmaceutical giants Novartis and Bayer challenge India's drug-patent rules, our correspondents discuss the potential implications for health care in the developing world Subscribe NOW to The Economist: http://econ.st/1Fsu2Vj Get more The Economist Follow us: https://twitter.com/TheEconomist Like us: https://www.facebook.com/TheEconomist View photos: https://instagram.com/theeconomist/ The Economist videos give authoritative insight and opinion on international news, politics, business, finance, science, technology and the connections between them.
Views: 18940 The Economist
Generic medicines and drugs
 
01:01
Generic drugs are drugs and medicines, which is equivalent to the branded products in dose, strength, route of administration, quality, performance and intended use. It can also term refers to any type of drug marketed under the chemical name without advertising, or the chemical composition of the drug instead of the brand under which the drug is selling the name. Although it can not be associated with a particular company, the drugs are often subject to government regulations in the countries in which they are dispensed with. It is labeled with the manufacturer's name and generic name does not have the name of the United States or the international common name for the drug approved. #Generic medicines and drugs
Views: 20 suman gupta
Health Subcommittee Hearing on "Generic Drug & Biosimilars & User Fees"
 
02:21:15
The Subcommittee on Health held a hearing on Thursday, February 9, 2012, at 10:00 a.m. in 2123 Rayburn House Office Building, entitled "Review of the Proposed Generic Drug and Biosimilars, User Fees and Further Examination of Drug Shortages."
Views: 126 EnergyCommerce
Protest for cheap medicine outside office of  Novartis, which wants generic drugs patented
 
02:00
SHOTLIST 1. Protesters shouting slogans against Swiss drug company Novartis 2. Mid of protesters near the Novartis office headquarters 3. Close of the poster holding sign reading (English) "Novartis: Making a killing in profits" 4. Wide of police stopping the protesters 5. Protesters chanting slogans 6. SOUNDBITE (English) Eldred Tellis, Consultant on Drug Abuse and HIV/AIDS Programmes: "If they (Novartis) get their way, we may have no access to any drugs. I mean even common drugs have become very very costly for the common man, and right now they are trying to kill this pharmacy we have in the developing world, Indian generic manufacturers they want out of business because they want to make money. All these multinationals, they don't care about the poor man, they don't care about people getting well." 7. Protesters carrying giant capsule 8. Police and protesters 9. SOUNDBITE (English) Sherry Dubois, field Coordinator - Medecins sans Frontieres (Doctors Without Borders): "Quit doing the patent laws. Let India provide drugs for the world, like they can. We're putting the drugs for the people above profit." 10. Wide of the protestors outside Novartis office 11. Cutaway of police taking pictures 12. Cutaway of HIV positive patient Ramesh Bhandari 13. SOUNDBITE (Hindi) Ramesh Bhandari , HIV positive patient "We are not able to afford the drugs, as the monthly expenses for the medicines are close to 5-thousand Rupees a month (around 100 US dollars). If we have to spend even more....nowadays our income is not more then 5-thousand Rupees or 6-thousand Rupees (109 US dollars). So what are we going to spend on medicines, and what will we spend on food?" 14. Protesters walking down the street. STORYLINE People living with HIV, rights groups and activists from Medecins Sans Frontieres (MSF) held a protest outside the Novartis Company's Headquarters in Mumbai on Friday, demanding the right to cheap drugs. The Swiss drugmaker Novartis' six year legal battle against the Indian government, now at India's Supreme Court, may force India to grant patents for generic drugs, making them unaffordable. In a case that could affect India's role as drug provider to the developing world, the Supreme Court will give a verdict on whether the government had the right to deny a patent to Novartis AG for its lifesaving cancer treatment Gleevec. Aid groups say a victory for the company could open the door to patenting dozens of other generic medicines made by India's drug industry and sold to needy nations at far lower costs than those charged by Western drug manufacturers. "All these multinationals, they don't care about the poor man, they don't care about people getting well," said Eldred Tellis, a Consultant on Drug Abuse and HIV/AIDS Programmes. The case, launched soon after India passed its Patent Act in 2005, revolves around a legal provision aimed at preventing companies from seeking patents or extensions based on minor changes to existing treatments - a practice known as "evergreening" that is common in Europe and the United States. The provision has allowed India to reject patents for a range of older drugs for cancer, AIDS, tuberculosis, malaria and other illnesses that are made by India's generics industry. It also led to the rejection of Novartis' application for Gleevec, in which it argued a newer, more easily absorbed version qualified for a patent because it was demonstrably more effective. The blockbuster drug keeps chronic myeloid leukemia and some other cancers in remission. Its earlier version was ineligible for an Indian patent because the country gives no protection to drugs invented before 1995. India now makes one-fifth of the world's generics, sending about half abroad. You can license this story through AP Archive: http://www.aparchive.com/metadata/youtube/38f2930bac94705dcc23fda29ddd8eac Find out more about AP Archive: http://www.aparchive.com/HowWeWork
Views: 378 AP Archive
TPP: Corporate Power Trumps All (with Prof. Brook K Baker)
 
12:55
The importance of the Indian Supreme Court's decision on generic drugs, why the bar is lower for generic drug production in the United States,why Pharma companies drive inefficiency and threaten global health, why pharma companies are primarily marketing firms , why medicine is a "Global Public Good" and why "free trade agreements" are simply a giveaway for corporations... This clip from the Majority Report, live M-F at 12 noon EST and via daily podcast at http://Majority.FM Subscribe to us on YouTube: http://youtube.com/user/SamSeder
White Guy Goes High On Indian Supreme Court's Ruling on Generic Drugs in Novartis Case
 
17:48
Are you interested in the current affairs and the happenings of India & Pakistan? Want to watch an unbiased view, with minute by minute updates of the current scenario? Vande Mataram India is the right place to be! Watch Latest News Headlines 2018, Geo News Headlines 2018, India Pakistan News Headlines 2018, Aaj tak News Headlines 2018, Express News Headlines 2018, AAJ News Headlines 2018, Pakistani Media On Narendra Modi,Pakistani Media On India,Developing India,India Against Corruption,India Against Pakistan,News Updates. Please subscribe for breaking News Headlines and Updates. Forum discussions, talk shows and much more. Stay tuned For More News Subscribe Now - https://goo.gl/6w8tYQ
Views: 1451 Vande Mataram India
Americans Pay Double For Prescriptions
 
00:52
Researchers at Harvard Medical School say that Prescription drug costs occupy nearly one-fifth of American healthcare spending and Americans spend more than double that of other industrialized nations on prescriptions, which blame on too-long exclusivity delaying generic drugs. The cost of prescription drugs in the United States f outprices other countries by far and their rising costs are causing concern in every part of the healthcare industry. A doctor's group called for the United States to move to a single-payer health insurance system, potentially similar to those in Canada and England http://www.upi.com/Health_News/2016/08/23/Americans-pay-more-than-double-what-other-nations-pay-for-drugs/8501471964588/ http://www.wochit.com This video was produced by YT Wochit News using http://wochit.com
Views: 125 Wochit News
What's the difference between brand & generic medications?
 
00:22
Felicia - a mailmyprescriptions.com pharmacy technician - elaborates on the difference between brand and generic medications. Mailmyprescriptions.com is America’s first mail-order pharmacy to offer direct-from-the-wholesaler, guaranteed low pricing on FDA-approved generic drugs. For more information on how you can save on your generic prescription drugs, visit https://goo.gl/NNAoeA Subscribe for more updates, news, and videos. STAY CONNECTED: Facebook: https://www.facebook.com/mailmyprescriptions/ Instagram: https://www.instagram.com/mailmyprescriptions/ Twitter: https://twitter.com/mailmyrx LinkedIn: https://www.linkedin.com/company/mailmyprescriptions.com
Deep Dive: Drug Prices and Access to Medicine
 
01:24:08
The average annual cost of cancer drugs in the US now exceeds $100,000 and the price of more than 200 generic drugs doubled from 2013 to 2014. That puts them far out of reach for countess ailing people, including many with decent insurance. The industry argues that it needs the revenue for the complex and expensive research that leads to better treatments, but pharmaceutical executives are being pilloried in editorials and Congressional hearings, and consumer groups say marketing and profit are the real drivers of price. What’s behind the cost of drugs? What are the options for people who can’t pay it? Featuring: Kirsten Axelsen Geoffrey Chaiken Ken Davis Ezekiel Emanuel Lisa Gill Alan Weil, Moderator Kiah Williams
Views: 1212 The Aspen Institute
Inhalation & Nasal Spray Generic Drugs Market by Manufacturers, Regions, Type and Application
 
00:26
Visit here- https://www.wesrch.com/electronics/paper-details/press-paper-EL1GP9000ARHU-inhalation-nasal-spray-generic-drugs-market-by-manufacturers-regions-type-and-application Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Inhalation & Nasal Spray Generic Drugs in these regions, from 2012 to 2023 (forecast), covering North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast Asia) South America (Brazil, Argentina, Columbia)
Views: 0 Shanya Singh
Trump highlights progress in eliminating government regulations
 
09:45
The president speaks about health care choice for veterans and affordable generic drugs.
Views: 3906 ABC News